Search
Efatutazone
go.drugbank.com/drugs/DB11894InvestigationalEfatutazone has been used in trials studying the treatment of Lymphoma, Liposarcoma, Solid Tumors, Multiple Myeloma, and Recurrent Thyroid Cancer, among others.
Triapine
go.drugbank.com/drugs/DB11940InvestigationalTriapine has been used in trials studying the treatment of Leukemia, Lung Cancer, Kidney Cancer, Prostate Cancer, and Pancreatic Cancer, among others.
Uprosertib
go.drugbank.com/drugs/DB11969InvestigationalUprosertib has been used in trials studying the treatment of Cancer, Melanoma, Solid Tumours, Cervical Cancer, and HER2/Neu Negative, among others.
PF-03715455
go.drugbank.com/drugs/DB12138InvestigationalPF-03715455 has been used in trials studying the treatment of Asthma, Pulmonary Disease, Chronic Obstructive, and Chronic Obstructive Pulmonary Disease (COPD).
TAK-733
go.drugbank.com/drugs/DB12241InvestigationalTAK-733 has been used in trials studying the treatment of Advanced Metastatic Melanoma, Advanced Nonhematologic Malignancies, and Advanced Non-hematologic Malignancies.
Taladegib
go.drugbank.com/drugs/DB12550InvestigationalTaladegib has been used in trials studying the treatment of Solid Tumor, COLON CANCER, BREAST CANCER, Advanced Cancer, and Rhabdomyosarcoma, among others.
Samatasvir
go.drugbank.com/drugs/DB12660InvestigationalSamatasvir has been used in trials studying the treatment of Hepatitis C, Chronic, Chronic Hepatitis C Virus, and Chronic Hepatitis C Infection.
Pyroxamide
go.drugbank.com/drugs/DB12847InvestigationalPyroxamide has been used in trials studying the treatment of Leukemia, Lymphoma, Small Intestine Cancer, Precancerous Condition, and Myelodysplastic Syndromes, among others.
Samarium Sm-153
go.drugbank.com/drugs/DB12905InvestigationalSamarium 153 has been used in trials studying the supportive care of Pain, Lung Cancer, Breast Cancer, Prostate Cancer, and Metastatic Cancer.
Recombinant CD40-ligand
go.drugbank.com/drugs/DB15015InvestigationalRecombinant CD40-ligand is under investigation in clinical trial NCT00053391 (Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma).
Categories: Amino Acids, Peptides, and Proteins, Intercellular Signaling Peptides and Proteins